Should You Buy, Sell or Hold TLRY Stock After Q2 Earnings?

Tilray Brands (NASDAQ: TLRY) recently reported its **fiscal second-quarter 2026 earnings**, delivering **record net revenue of about $217.5 million**, a 3 % increase from the prior year and above Wall Street’s expectations. Management credited the growth to disciplined execution across its diversified portfolio, including **cannabis, beverage, wellness, and distribution segments**. The company’s adjusted EBITDA for the quarter was approximately **$8.4 million**, and while Tilray narrowed its net loss compared with the prior year, it still remained unprofitable for the period. In detail, global cannabis revenue rose thanks to strong international demand, even as the beverage segment fell due to ongoing headwinds. The distribution business delivered its highest quarterly revenue ever, while the wellness unit was flat. Tilray finished the quarter with a strong balance sheet — roughly $292 million in cash and marketable securities and a positive net cash position after reducing debt. Since the earnings release, TLRY stock has seen modest gains and trades above its longer‑term trend line, hinting at possible bullish momentum. Analysts note the company’s diversified business model and global cannabis growth as reasons for optimism, although continued profitability concerns and segment challenges could temper expectations. #TilrayBrands #CannabisStocks #EarningsReport #StockAnalysis #SlimScan #GrowthStocks #CANSLIM